MMV009085

• CAT Number: I041138
• CAS Number: 298217-59-1
• Molecular Formula: C22H22N2O6
• Molecular Weight: 410.42
• Purity: ≥95%
• Synonyms: 6,13-bis(4-hydroxybutyl)-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaene-5,7,12,14-tetrone
• InChI: InChI=1S/C22H22N2O6/c25-11-3-1-9-23-19(27)13-5-7-15-18-16(8-6-14(17(13)18)20(23)28)22(30)24(21(15)29)10-2-4-12-26/h5-8,25-26H,1-4,9-12H2
• InChIKey: XZBVMYTVRGGDKI-UHFFFAOYSA-N
• SMILES: C1=CC2=C3C(=CC=C4C3=C1C(=O)N(C4=O)CCCCO)C(=O)N(C2=O)CCCCO

MMV009085（Cat No.:I041138）is a potent small molecule inhibitor developed by the Medicines for Malaria Venture (MMV) for the treatment of malaria. It targets Plasmodium falciparum, the parasite responsible for the most severe form of malaria, by inhibiting a key enzyme involved in its lifecycle. MMV009085 disrupts parasite growth, reducing its ability to replicate and cause infection. This compound has shown promise in preclinical studies for its effectiveness against drug-resistant strains of malaria. MMV009085 represents a potential new therapeutic option in the fight against malaria, addressing the urgent need for novel antimalarial treatments.